See All Slides - tctmd.com

Slides

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Thomas Engstroem

October 31, 2017

Presentation TCT 2017

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Philippe Genereux

October 31, 2017

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE III: Fu-Wai Left Main Registry

Presenter: Antonio Colombo, David E. Kandzari, Bo Xu

October 31, 2017

Presentation TCT 2017

Case #6: A Decapitated Left Main Coronary Stent

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Chee Yang Chin

October 31, 2017

Presentation TCT 2017

Fundamentals for CTO PCI Success

Presenter: James C. Spratt, Simon J. Walsh, Emmanouil S. Brilakis

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

ACURATE Neo Insights From EU Operators (With Case Examples)

Presenter: Ulrich Schäfer

October 31, 2017

Presentation TCT 2017

Watchman: Step-by-step Recorded Case

Presenter: Ramon Quesada, Robert J. Sommer, Matthew J. Price

October 31, 2017

Presentation TCT 2017

Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans

Presenter: Juan F. Granada

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Anthony H. Gershlick

October 31, 2017

Advertisement

Slides

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Exploring Diversity and Generalizability of EXCEL/NOBLE III: Fu-Wai Left Main Registry

Case #6: A Decapitated Left Main Coronary Stent

Fundamentals for CTO PCI Success

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

ACURATE Neo Insights From EU Operators (With Case Examples)

Watchman: Step-by-step Recorded Case

Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content